
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.5
547547 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
6,069 Listeners
417 Listeners
1,875 Listeners
990 Listeners
2,854 Listeners
1,015 Listeners
7,716 Listeners
1,015 Listeners
1,381 Listeners
7,844 Listeners
25,717 Listeners
5,655 Listeners
4,529 Listeners
111,121 Listeners
53 Listeners
2,239 Listeners
2,043 Listeners
240 Listeners
23,937 Listeners
10,085 Listeners
1,286 Listeners
5,415 Listeners
15,937 Listeners
1,192 Listeners
413 Listeners
5,981 Listeners
5,425 Listeners
15,311 Listeners
2,170 Listeners
59 Listeners
46 Listeners
95 Listeners
4 Listeners
84 Listeners